Corrigendum: Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?

In the published article, there was an error in the legend for Figure 5 as published. Part (A) incorrectly read “The comparison of the total-average proteinuria” instead of “The comparison of the time-average proteinuria”. The corrected legend appears below.

Figure 5.

(A) The comparison of the time-average proteinuria among patients with IgAN, cIgAN/MN and MN. (B) Proteinuria persisted means patients could not achieve complete or partial proteinuria remission during follow-up, which was were calculated according to the Kaplan-Meier method (log-rank test). ns, not significant.

In the published article, there was also a word expression error.

A correction has been made to Results, Follow-Up Evaluation, paragraph number 4. This sentence previously stated:

“Compared to IgAN, the cumulative incidence of persistent proteinuria after therapy in patients with cIgAN/MN was lower than in IgAN (P=0.001).”

The corrected sentence appears below:

“Compared to IgAN, the cumulative incidence of persistent proteinuria after therapy in patients with cIgAN/MN was higher than in IgAN (P=0.001).”

The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.